Atlas Trials

Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

Clinical trial NCT00410930 · TERMINATED

Trial details

NCT number
NCT00410930
Sponsor
Stallergenes Greer
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Allergy
Start date
2002-11-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.